EGRX

Eagle Pharmaceuticals, Inc.

Delisted

EGRX was delisted on the 2nd of October, 2024.

152 hedge funds and large institutions have $328M invested in Eagle Pharmaceuticals, Inc. in 2022 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 59 increasing their positions, 48 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
152
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.78M
Puts
$15K
Net Calls
Net Calls Change

Top Sellers

1 -$36.5M
2 -$3.52M
3 -$2.33M
4
Millennium Management
Millennium Management
New York
-$2.2M
5
Citadel Advisors
Citadel Advisors
Florida
-$2.09M
Name Holding Trade Value Shares
Change
Change in
Stake
101
$218K
102
$212K
103
$211K
104
$208K
105
$207K
106
$202K
107
$181K
108
$163K
109
$160K
110
$140K
111
$137K
112
$136K
113
$101K
114
$88K
115
$85K
116
$80K
117
$73.8K
118
$58.5K
119
$52.9K
120
$30.8K
121
$29.2K
122
$27K
123
$24.9K
124
$23.3K
125
$22.3K